SA
LTRN icon

Sanctuary Advisors’s Lantern Pharma LTRN Stock Holding History

Sanctuary Advisors’s Portfolio LTRN Stock Details LTRN Fund Activity
Bought
Maintained
Sold
Quarter Market Value Status Shares Change in
Stake 		Trade Value Portfolio Weight Portfolio Position
2025
Q3 		– Sell
-10,000
Closed -$31.6K – 2494
2025
Q2 		$31.6K Hold
10,000
– – ﹤0.01% 2327
2025
Q1 		$35.4K Hold
10,000
– – ﹤0.01% 2153
2024
Q4 		$48.1K Buy
+10,000
New +$34.2K ﹤0.01% 2357

Other funds holding LTRN

BCM
BIOS Capital Management Fort Worth, Texas $52.9M AUM 30.51% 1-Year Est. Return
Vanguard Group
Vanguard Group Malvern, Pennsylvania $6.9T AUM 27.45% 1-Year Est. Return
CM
CM Management Gulf Breeze, Florida $120M AUM 37.12% 1-Year Est. Return
Renaissance Technologies
Renaissance Technologies New York $63.9B AUM 45.56% 1-Year Est. Return
Geode Capital Management
Geode Capital Management Boston, Massachusetts $1.61T AUM 30.72% 1-Year Est. Return
VC
Voss Capital Houston, Texas $1.88B AUM 1.03% 1-Year Est. Return
NA
NewEdge Advisors New Orleans, Louisiana $27.7B AUM 22.98% 1-Year Est. Return
BlackRock
BlackRock New York $5.72T AUM 30.48% 1-Year Est. Return
Dimensional Fund Advisors
Dimensional Fund Advisors Austin, Texas $481B AUM 30.42% 1-Year Est. Return
Susquehanna International Group
Susquehanna International Group Bala Cynwyd, Pennsylvania $893B AUM 36.07% 1-Year Est. Return

Sanctuary Advisors's LTRN Position: Q3 2025 in Review

Sanctuary Advisors sold out of Lantern Pharma (LTRN) in Q3 2025, closing a stake of 10,000 shares — an estimated $31.6K sold.

Sanctuary Advisors first reported a position in LTRN in Q4 2024 and held it in 3 quarters. The position peaked at $48.1K in Q4 2024. 30 funds tracked by Wall St. Rank hold LTRN as of Q3 2025.

  • Sanctuary Advisors reported no remaining Lantern Pharma position as of Q3 2025 after selling out during the quarter.
  • Sanctuary Advisors sold 10,000 Lantern Pharma shares in Q3 2025, an estimated $31.6K.
  • Sanctuary Advisors first reported a position in Lantern Pharma in Q4 2024 and held it in 3 quarters.
  • Sanctuary Advisors's Lantern Pharma position peaked at $48.1K in Q4 2024.
  • 30 funds tracked by Wall St. Rank held Lantern Pharma as of Q3 2025.

Based on Sanctuary Advisors's 13F filing for Q3 2025, filed 6 Jan 2026.